Free Trial
NASDAQ:IMCC

IM Cannabis (IMCC) Stock Price, News & Analysis

IM Cannabis logo
$2.08 +0.08 (+4.00%)
(As of 12/20/2024 05:31 PM ET)

About IM Cannabis Stock (NASDAQ:IMCC)

Key Stats

Today's Range
$1.91
$2.20
50-Day Range
$1.84
$3.99
52-Week Range
$1.13
$8.10
Volume
15,021 shs
Average Volume
106,126 shs
Market Capitalization
$4.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

IM Cannabis Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
1st Percentile Overall Score

IMCC MarketRank™: 

IM Cannabis scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for IM Cannabis.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of IM Cannabis is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of IM Cannabis is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    IM Cannabis has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    10.73% of the float of IM Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    IM Cannabis has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IM Cannabis has recently increased by 752.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    IM Cannabis does not currently pay a dividend.

  • Dividend Growth

    IM Cannabis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.73% of the float of IM Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    IM Cannabis has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IM Cannabis has recently increased by 752.00%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 2 people have searched for IMCC on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, IM Cannabis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.91% of the stock of IM Cannabis is held by insiders.

  • Percentage Held by Institutions

    Only 7.68% of the stock of IM Cannabis is held by institutions.

  • Read more about IM Cannabis' insider trading history.
Receive IMCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter.

IMCC Stock News Headlines

IM Cannabis Corp Raises Funds Amid Global Challenges
IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript
I was wrong. Dead wrong.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
IM Cannabis Reports Third Quarter Financial Results
See More Headlines

IMCC Stock Analysis - Frequently Asked Questions

IM Cannabis' stock was trading at $2.1420 at the beginning of 2024. Since then, IMCC shares have decreased by 2.9% and is now trading at $2.08.
View the best growth stocks for 2024 here
.

Shares of IM Cannabis reverse split on the morning of Friday, July 12th 2024. The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), General Electric (GE) and AppLovin (APP).

Company Calendar

Today
12/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IMCC
Fax
N/A
Employees
340
Year Founded
N/A

Profitability

Net Income
$-7,040,000.00
Pretax Margin
-29.52%

Debt

Sales & Book Value

Annual Sales
$51.39 million
Book Value
$4.55 per share

Miscellaneous

Free Float
2,100,000
Market Cap
$4.64 million
Optionable
Not Optionable
Beta
0.93
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:IMCC) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners